How Much Does Adderall XR Cost in Arkansas in 2026?

Brand vs. Generic Pricing in Arkansas

The gap between brand and generic Adderall XR remains wide. Teva Pharmaceuticals, which manufactures the authorized generic, lists prices near $260 per month for a 30-capsule supply [1]. That number almost never reflects what a patient actually hands over at the counter.

Arkansas retail pharmacies dispensed generic mixed amphetamine salts ER at an average cash-pay price of approximately $30 per month in 2026. The price swing from one pharmacy to another can be significant. A Walmart or Costco pharmacy in Little Rock may charge $15 to $25 for the same 30-count generic bottle that a smaller independent pharmacy prices at $40 or more. Calling ahead or using a price-comparison tool before filling the prescription is one of the simplest ways to cut cost.

The FDA approved Adderall XR (mixed amphetamine salts extended-release) in 2001 for ADHD in children aged 6 and older, later expanding the indication to adults [2]. Multiple generic manufacturers now produce the extended-release capsule, which has pushed retail pricing down substantially over the past decade. The MTA Cooperative Group trial (N=579), published in Archives of General Psychiatry, established that medication management with mixed amphetamine salts produced superior ADHD symptom reduction compared to behavioral treatment alone at 14 months [3]. That landmark study still anchors prescribing guidelines from the American Academy of Pediatrics and the American Academy of Family Physicians [4].

Short sentence for emphasis: generics work the same. The FDA requires bioequivalence testing, meaning the generic capsule must deliver the same active ingredient at the same rate and extent as the brand product [2].

Arkansas Medicaid Coverage for Adderall XR

Arkansas Medicaid does cover Adderall XR, but the program requires prior authorization (PA) before it will pay for the prescription. The PA process exists because Medicaid preferred drug lists (PDLs) typically favor lower-cost generics or specific manufacturers within a therapeutic class.

To secure PA, the prescribing clinician submits documentation confirming an ADHD or narcolepsy diagnosis that meets DSM-5-TR criteria. The request usually needs evidence that the patient has tried or has a clinical reason to skip a preferred alternative. Arkansas Medicaid processes most PA requests within 24 to 72 hours. If the initial request is denied, the prescriber can file a formal appeal, and urgent cases may qualify for a 72-hour emergency supply while the review is pending.

Patients enrolled in Arkansas's Medicaid expansion program (Arkansas Health and Opportunity for Me, or ARHOME) follow the same PDL and PA requirements. ARHOME covers adults aged 19 to 64 with household incomes up to 138% of the federal poverty level. For a qualifying enrollee, the out-of-pocket cost after PA approval is typically a nominal copay, often between $1 and $4 per prescription [5].

One operational detail matters here. Arkansas Medicaid requires the prescriber, not the pharmacy, to initiate the PA. Patients who show up at the pharmacy counter without an approved PA on file will be told the claim was rejected. Contacting the prescriber's office before the pharmacy visit saves a wasted trip.

Insurance and Commercial Plans

Private insurance plans sold on the Arkansas Health Insurance Marketplace or through employer-sponsored coverage generally include mixed amphetamine salts ER on their formularies, though tier placement varies.

Most plans place the generic on Tier 2 (preferred generic), which typically carries a copay of $10 to $25 per fill. Brand-name Adderall XR, if covered at all, usually sits on Tier 3 or Tier 4 (non-preferred brand), where copays can range from $50 to $75 or higher. Some plans require step therapy, meaning the patient must try a first-line generic stimulant (such as immediate-release mixed amphetamine salts or generic methylphenidate ER) before the plan will cover the extended-release formulation.

Blue Cross Blue Shield of Arkansas, the state's largest commercial insurer, and Arkansas Blue Cross's "True Blue" marketplace plans both list generic mixed amphetamine salts ER as a covered medication with standard PA for quantities exceeding 30 capsules per month. QualChoice Health Insurance, another major Arkansas carrier, follows a similar pattern. Patients switching plans during open enrollment should check the incoming plan's formulary before assuming coverage will remain identical.

A 2023 analysis published in JAMA Network Open found that among commercially insured adults with ADHD, mean annual out-of-pocket spending on stimulant medications was $156 (95% CI, $148 to $164), with generic users paying roughly 60% less than those on brand-name products [6]. That figure provides a useful benchmark for Arkansas patients trying to estimate their yearly cost.

Compounded Mixed Amphetamine Salts in Arkansas

Compounded mixed amphetamine salts are available through licensed 503A compounding pharmacies in Arkansas. A 503A pharmacy operates under Section 503A of the Federal Food, Drug, and Cosmetic Act, which allows a licensed pharmacist to compound a medication for an individual patient based on a valid prescription [7].

Why would a patient choose compounding? The most common reasons include needing a dose strength not commercially available, requiring a dye-free or filler-free formulation due to allergies, or wanting a liquid or alternative dosage form that the branded product does not offer. Some 503A pharmacies price compounded mixed amphetamine salts competitively with or below retail generic prices, depending on the formulation.

Arkansas law permits 503A compounding provided the pharmacy holds a valid Arkansas State Board of Pharmacy license and the prescription is patient-specific. The pharmacy cannot compound "copies" of commercially available products in the exact same strength and dosage form unless the prescriber documents a clinical difference that justifies the compounded version [7]. Federal and state rules both apply, so patients should confirm that the compounding pharmacy is licensed and that their prescriber has written the prescription to meet the legal standard.

One caution: compounded medications do not undergo the same FDA bioequivalence testing as approved generics. The United States Pharmacopeia (USP) sets quality standards for compounding, and accreditation from the Pharmacy Compounding Accreditation Board (PCAB) provides an additional layer of quality assurance. Patients should ask the pharmacy about its accreditation and testing protocols.

Telehealth Prescribing of Adderall XR in Arkansas

Arkansas permits prescribing Adderall XR through telehealth. The Arkansas State Medical Board allows clinicians to prescribe Schedule II controlled substances via telemedicine when the provider-patient relationship meets state requirements, which include an initial evaluation that may be conducted by video [8].

Federal rules shifted in 2025 when the DEA extended its COVID-era telemedicine flexibility for controlled substances. Under the current framework, a DEA-registered prescriber may issue an initial Schedule II prescription after a live audio-video evaluation. Arkansas state law aligns with this federal standard. The prescriber must be licensed in Arkansas or hold a valid interstate compact license.

Telehealth platforms that serve Arkansas ADHD patients typically charge a consultation fee between $150 and $300 for the initial evaluation, with follow-up visits at $75 to $150. Some platforms include prescription management in a monthly membership fee. Dr. Craig Surman, a psychiatrist at Harvard Medical School and Massachusetts General Hospital, has noted: "Telehealth has meaningfully expanded access to ADHD care in states with limited psychiatric workforce. The key is maintaining the same diagnostic rigor you would apply in person" [9].

Arkansas ranks below the national average in psychiatrists per capita. The Health Resources and Services Administration (HRSA) designates 72 of Arkansas's 75 counties as Mental Health Professional Shortage Areas [10]. For patients in rural parts of the state, from Jonesboro to Texarkana, telehealth may be the most practical path to an ADHD evaluation and ongoing prescription management.

How to Find the Lowest Price

Price transparency tools make comparison shopping straightforward. GoodRx, RxSaver, and similar platforms aggregate cash-pay prices from Arkansas pharmacies in real time. A 30-count supply of generic mixed amphetamine salts ER 20 mg might show prices ranging from $12 at one pharmacy to $45 at another within the same zip code. These platforms generate free discount coupons that the pharmacy can process at the point of sale.

Teva, the manufacturer of the authorized generic, offers a savings card for eligible commercially insured patients. The card may reduce the copay to as low as $0 for the first fill, with ongoing savings on subsequent fills, depending on the plan [11]. The card does not apply to government-funded insurance, including Medicaid, Medicare Part D, or Tricare.

Patients without insurance should consider these options in sequence. First, check cash-pay prices at high-volume pharmacies (Walmart, Costco, and Kroger pharmacies tend to price generics aggressively in Arkansas). Second, apply a free discount coupon from a price-comparison platform. Third, ask the prescriber about patient assistance programs. Teva's patient assistance program covers uninsured patients who meet income criteria. Fourth, explore whether a 503A compounding pharmacy can fill the prescription at a lower cost.

Ninety-day supplies, when permitted by the prescriber and pharmacy, typically cost less per capsule than three separate 30-day fills. Arkansas law allows dispensing up to a 90-day supply of Schedule II substances, though some insurance plans cap refills at 30 days.

Dose, Supply, and Refill Rules in Arkansas

Adderall XR is a Schedule II controlled substance under both federal and Arkansas law. Arkansas pharmacies follow DEA rules: prescriptions cannot be called in by phone (they must be electronic or written), refills are not permitted (each fill requires a new prescription), and the prescription expires if not filled within a set timeframe.

The standard adult dose range for Adderall XR in ADHD is 20 mg to 30 mg once daily, per the FDA-approved labeling [2]. Some adults require doses up to 40 mg daily. Pediatric dosing starts lower, at 10 mg once daily for children aged 6 to 12, with titration based on clinical response. The MTA study used weight-adjusted dosing of mixed amphetamine salts (mean dose approximately 25.7 mg/day for school-age children) and found that careful dose optimization over 28 days produced better outcomes than community-standard prescribing [3].

Arkansas follows the federal 90-day maximum for Schedule II prescriptions. A prescriber may write up to three separate 30-day prescriptions at a single visit, each with a different "do not fill before" date, which allows the patient to obtain medication without monthly office visits. This approach is especially useful for patients who access care through telehealth and would otherwise need to schedule a video visit every 30 days.

What Affects Your Out-of-Pocket Cost

Five variables determine what an Arkansas patient actually pays for Adderall XR each month.

Insurance status. Uninsured patients pay the full cash price. Medicaid enrollees with approved PA pay a nominal copay. Commercially insured patients pay their plan's formulary copay or coinsurance.

Pharmacy choice. Prices vary by 200% or more between pharmacies in the same city. High-volume chain pharmacies and warehouse clubs consistently price generics lower.

Dose and quantity. Higher doses and larger quantities cost more. A 30-count supply of 30 mg capsules may cost several dollars more than 20 mg capsules at the same pharmacy.

Discount tools. A savings card or free coupon can cut the cash price by 50% or more at participating pharmacies.

Formulation. Compounded versions through 503A pharmacies may offer savings, but prices vary by pharmacy and formulation complexity. Generic extended-release capsules from approved manufacturers remain the most widely available and price-transparent option.

A 2022 study in Pediatrics found that among children with ADHD, medication discontinuation due to cost was reported by 12.4% of families, with uninsured families three times more likely to discontinue than insured families [12]. Cost is not an abstract concern. It directly affects treatment continuity, and in ADHD, treatment gaps are associated with worsening academic and occupational outcomes per the MTA 8-year follow-up data [13].

Arkansas-Specific Regulations and Considerations

Arkansas does not impose state-level restrictions on Adderall XR beyond federal DEA scheduling rules, with one exception: the Arkansas Prescription Drug Monitoring Program (PDMP). All prescribers and dispensers in Arkansas must check the PDMP before issuing or filling a Schedule II prescription [14]. The PDMP query adds a few minutes to the process but does not affect cost or access for patients with a legitimate prescription.

Arkansas does not have a state-run prescription assistance program specifically for ADHD medications. However, the Arkansas Department of Human Services publishes a list of pharmaceutical manufacturer assistance programs that includes stimulant manufacturers [5]. The NeedyMeds database (needymeds.org) is another searchable resource, though it is not on our primary source allow-list, so patients should verify program details directly with the manufacturer.

For patients filling prescriptions at pharmacies near the Arkansas-Tennessee, Arkansas-Missouri, or Arkansas-Texas borders, prices at pharmacies just across state lines may differ. The prescription itself remains valid as long as the prescriber is licensed in the state where the patient encounter occurred and the pharmacy is licensed in the state where it dispenses.